Radiopharm Theranostics Limited (RAD) Income Statement
9 Followers
Radiopharm Theranostics Limited Income Statement
Last quarter (Q4 2022), Radiopharm Theranostics Limited's total revenue was AU$―. In Q4, Radiopharm Theranostics Limited's net income was AU$―. See Radiopharm Theranostics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
AU$ 8.83K
Cost of Revenue
-
Gross Profit
AU$ 8.83K
Operating Expense
AU$ 19.93M
Operating Income
AU$ -19.92M
Net Non Operating Interest Income Expense
AU$ -9.35M
Other Income Expense
AU$ -1.03M
Pretax Income
AU$ -30.29M
Tax Provision
AU$ 44.40K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
AU$ -30.34M
Basic EPS
AU$ -0.16
Diluted EPS
AU$ -0.16
Basic Average Shares
AU$ 187.49M
Diluted Average Shares
AU$ 187.49M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
-
Net Income From Continuing And Discontinued Operation
AU$ -30.34M
Normalized Income
AU$ -30.34M
Interest Expense
AU$ 9.35M
EBIT
AU$ -20.94M
EBITDA
AU$ -17.96M
Currency in AUD
Radiopharm Theranostics Limited Earnings and Revenue History